Market Research News

Thursday 12 October 2017

Cell Counting Market Projected to reach USD 1.7 billion by 2025 : Grand View Research , Inc.

Global Cell Counting Market is expected to reach USD 1.7 billion by 2025, according to a new report by Grand View Research, Inc. Government initiatives working to promote development of cell therapeutics, wherein cell counting plays an imperative role, is expanding growth prospects for the market. As a result of extensive R&D activities, the number of diseases treated with the help of stem cells increased to 82 in 2016 from 27 in 2005. Also, California Institute for Regenerative Medicine’s funding of USD 271 million for stem cell therapy created 12 R&D facilities in California, and these facilities brought approximately USD 543 million funding. In addition, it is also funded by National Institutes of Health (NIH), which approximately invested USD 1,429 million in 2015.

Increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided significant boost to the market. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate generation of accurate results are likely to improve adoption of instruments over the coming years. For instance, in May 2016, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve quality of preclinical studies.

Full Research Report on Global Cell Counting Market Analysis:
http://www.grandviewresearch.com/industry-analysis/cell-counting-market

Further Key Findings From the Report Suggest:

Spectrophotometers accounted forthe largest market share in 2016. This can be attributed to high penetration in various applications such as toxicology studies, bioprocessing, and others
Automated counters were anticipated to grow at an exponential rate during the forecast period. Benefits such as short testing time, reduced error occurrence, and interoperator variability are expected to further increase demand for automated counters
In the end-use segment, research and academic institutes accounted for the largest market share in 2016, owing to growing number of government initiatives focused toward promoting R&D in various toxicology studies
Research and academic institutes are also expected to witness exponential growth opportunities, owing to the growing adoption of instruments for optimum drug concentration in therapeutics
North America held the largest share of the market, owing to increase in number of supportive initiatives to fund R&D, which is anticipated to result in higher adoption of automated instruments
Asia Pacific is anticipated to grow with a lucrative CAGR during the forecast period. This lucrative growth rate is a consequence of improvements in testing facilities
Level of competition is high as key players are adopting strategies such as new product development and strategic collaborations & agreements to gain competitive advantage

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Cell Counting Market on the basis of product, end use, and region:

Cell Counting Product Outlook (Revenue, USD Million, 2014 - 2025)

Instruments

Spectrophotometers
Flow Cytometers
Hematology Analyzers
Cell Counters

Consumables & Accessories

Reagents
Microplates
Others

Cell Counting End-use Outlook (Revenue, USD Million, 2014 - 2025)

Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Pharmaceutical & Biotechnology Companies
Others

Cell Counting Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.
Canada

Europe

UK
Germany
France
Italy
Spain

Asia Pacific

Japan
China
India

Latin America

Brazil
Mexico

Middle East & Africa

South Africa
Saudi Arabia

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cell-counting-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Artificial Ventilation And Anesthesia Masks Market Projected to reach USD 2,888.8 million by 2022 : Grand View Research,Inc.

Global ArtificialVentilation And Anesthesia Masks Market is expected to reach USD 2,888.8 million by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to market growth include rising number of operation and emergency room procedures coupled with growing demand novel products which can be used to carry out intubation process without removing the oxygen mask. Increase in the target disease has a direct impact on the number of operation room, emergency and intensive care procedures and is expected to boost usage rates of ventilation masks over the forecast period.

Increasing geriatric population is a major factor increasing the prevalence rate of several diseases. Additionally, growing prevalence of sleep apnea is one of the most significant growth drivers for these anesthesia and ventilation masks over the forecast period.

According to statistics published by the National Sleep Foundation in 2012, around 40 million Americans were affected by chronic sleep disorders. Furthermore, these patients are at a high risk of visiting emergency department and intensive care units, and as a consequence are expected to increase the demand of ventilation masks in the next seven years.

The market dynamics indicate that various players operating in this space compete on the basis of product specification and prices. The technology used to manufacture, quality of the product, and patient comfort are the key variables expected to impact the usage of these products. The healthcare providers assess the risk to the patient and determine the need to use invasive ventilation or non-invasive ventilation. The use of non-invasive masks in accident and trauma cases, lung failure and other emergency cases is a key factor contributing to the high usage rates of these products.

The market is segmented on the basis of application as operation room, intensive care units, emergency room, dental, and home care. In 2014 operating room held the maximum share of over 58% for low risk procedures and is expected to be the largest segment in the next seven years. Increase in insurance penetration, number of hospitals and dental centers to tap the high unmet needs in emerging economies is a key factor expected to boost the surgical volume and therefore these factors are expected to increase the demand for ventilation masks over the forecast period.

Full Research Report on Global Artificial Ventilation and Anesthesia Masks Market Analysis:
http://www.grandviewresearch.com/industry-analysis/artificial-ventilation-anesthesia-masks-market

Further key findings from the report suggest:

In 2014, North America dominated the overall market with a share of more than 50%. Key factors attributing to its large share include presence of robust healthcare infrastructure, which includes hospitals, emergency and dental centers.
Furthermore, in the U.S., the Affordable Care Act is a key driver encouraging millions of patients to opt for surgical treatments and utilize other healthcare services, and as a result is expected to boost usage rates of artificial ventilation and anesthesia masks over the forecast period.
Asia Pacific is expected to be the fastest growing market over the forecast period. Key factors attributing to its high growth are increase in public and private healthcare expenditure to build new hospitals, improve reimbursement scenario which lead to improvement in overall healthcare indicators.
Additionally, large population affected with various diseases is expected to increase the number of emergency, ICU and operating room procedures and as a result are expected to increase usage rates in these markets.
Key players operating in the market include Phillips Respironics, ResMed, Fisher & Paykel, CareFusion, Ambu, Drager, and others. These companies have an extensive portfolio of ventilation and CPAP masks.
Additionally, emergence of new players with novel product offerings such as SuperNO2VA from RMDevices is expected change market dynamics due to its ability to carry out inhalation anesthesia, artificial ventilation and intubation procedure simultaneously.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Artificial Ventilation And Anesthesia Masks Market on the basis of application, and region:

Global Artificial Ventilation and Anesthesia Masks Application Outlook (Market Revenue in USD Million, 2012 - 2022)

Artificial Ventilation and Anesthesia Masks Market, by Application for High Risk Procedures

Operation Room
Intensive Care Units
Emergency Room
Dental

Artificial Ventilation and Anesthesia Masks Market, by Application for Moderate Risk Procedures

Operation Room
Intensive Care Units
Emergency Room
Dental

Artificial Ventilation and Anesthesia Masks Market, by Application for Standard Risk Procedures

Operation Room
Intensive Care Units
Emergency Room
Dental
Homecare

Artificial Ventilation and Anesthesia Masks Regional Outlook (Revenue, USD Million, 2014 - 2022)

North America

U.S.
Canada

Europe

Germany
UK

Asia Pacific

China
India
RoW
Brazil
South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/ventilation-anesthesia-masks-market

Pharmacy Automation Devices Industry projected to grow at a CAGR of 7.3% from 2014 to 2020 : Grand View Research,Inc.

Pharmacy automation involves automation and mechanization of tasks that include distribution and handling medication processes carried out in heath care centers and specialty pharmacy centers. The Global PharmacyAutomation Devices Industry is projected to grow at a CAGR of 7.3% from 2014 to 2020 and reach over USD 8.99 billion.

Automation systems such as packaging and labeling systems, medication dispensing system, storage and retrieval systems, table-top counters and compounding systems are employed in order improve the efficacy of regular jobs within pharmacies. The market is expected to grow owing to features including system integration that increases productivity and time to clinicians for patient care, thereby lowering medication errors.

Rising demand for pharmaceutical products, progressively growing technology and demand for precise robotic equipment & tools to perform operations at a faster rate are expected to be the key factors for market growth. Untapped growth opportunities in countries such as Brazil, China, and India coupled with escalating demand for automation in pharmacy and healthcare operations is expected to drive growth over the forecast period.

The market was dominated by automated medication dispensing systems in 2013. It accounted for a share of over 47.8% owing to growing demand for accurate medication dispensing systems. Automated dispensing systems have the ability to reduce significantly error rates and the ability to dispense hands-free. They provide storage, recording of medication, distribution to resident care and computer controlled dispensation.

Full Research Report on Global Pharmacy Automation Devices Market Analysis:

http://www.grandviewresearch.com/industry-analysis/pharmacy-automation-market

Automated compounding systems are anticipated to grow rapidly at a CAGR of 8.4% from 2014 to 2020 owing to an increasing demand for mixing of medication and substantial decrease in total time to complete a dose.

The existence of IT healthcare systems and high rate of penetration in healthcare and pharmaceutical units resulted in North America occupying the largest regional market in 2013. It accounted for about 54.8% of the market revenue. Increasing healthcare overheads and R&D relevant to pharmacy automation devices are few factors responsible for its market share.

Asia Pacific is likely to grow at a CAGR of over 9.0% during the forecast period and is the most lucrative regional markets majorly due to improving healthcare infrastructure in emerging economies of China and India. Easy access available to new entrants including multinational pharmaceutical companies and distributors in this region coupled with the introduction of healthcare reforms in these countries is expected to drive market growth.

Key industry players include AmerisourceBergen Corporation, CareFusion Corporation, Accu-Chart Healthcare, ForHealth Technologies, GSE Scale Systems, Fulcrum Inc,McKesson Corporation, Innovation PharmaAssist Robotics, Pearson Medical Technologies, Health Robotics SRL, Kirby Lester, MedDispence, Pyxis Pharmacy Automation Systems, Medacist, MTS Medication Technologies, OmnicellInc, Cerner Corporation, Rice Lake Weighing Systems, Baxter International Inc., Aesynt Inc., ScriptPro LLC, Parat Systems Pharmacy Automation, Yuyama Co. Ltd, Swisslog Holding Ltd,Talyst Inc. and ScriptPro LLC.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Pharmacy Automation Devices Market on the basis of application, end-use and region:

Pharmacy Automation Devices Application Outlook

• Automated Medication Dispensing Systems

• Automated Packaging And Labeling Systems

• Automated Storage And Retrieval Systems

• Automated Medication Compounding Systems

• Table Top Tablet Counters

Pharmacy Automation Devices End-use Outlook

• Hospital Pharmacy

• Retail Pharmacy

Pharmacy Automation Devices Regional Outlook

• North America

• Europe

• Asia Pacific

• RoW

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-pharmacy-automation-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Compressor Oil Market Projected to reach USD 97.15 billion by 2024 : Grand View Research,Inc.

Global CompressorOil Market is expected to reach USD 97.15 billion by 2024, according to a new report by Grand View Research, Inc. Increasing industrialization in Asia Pacific and the Middle East is expected to remain a key driving factor for global compressor oil market over the forecast period.

Various attributes of compressor oil such as cooling, sealing and lubricating the internal components which ensure continuous operation and helps in reducing downtime and repair is also expected to drive its demand. Moreover, these lubricants maintain the equipment temperature and therefore keep them cool.

The equipment heating results in higher power consumption and wear & tear of the machine. Cost optimization practices adopted by various manufacturing companies are also expected to drive demand for compressor oil. It is observed that organizations have been implementing continuous improvement projects to reduce power consumption & maintain continuous operational flow undertake good lubrication practices.

Positive displacement based products are widely used in industries owing to their high performance and low maintenance cost. Therefore, the segment accounted for the majority of compressor oil consumed globally. Demand for positive displacement type is expected to develop at an approximate CAGR of 5.0% from 2016 to 2024.

Full Research Report On Global Compressor Oil Market Analysis:
http://www.grandviewresearch.com/industry-analysis/compressor-oil-market

Further key findings from the report suggest:

Global compressor oil market demand was 6.80 million tons in 2015 and is expected to reach 10.44 million tons by 2024, growing at a CAGR of 4.9% from 2016 to 2024
Synthetic was the leading base oil used in compressor oil and accounted for 43.2% of global volume in 2015. High performance associated with synthetic oils are expected to drive their demand over the forecast period.
Increasing global awareness with respect to environmental issues is anticipated to drive the bio-based oil demand. The segment is anticipated to grow at an estimated CAGR of 5.1% from 2016 to 2024.
Manufacturing and automotive sector together accounted for over half of the global demand in 2015. Energy industry is expected to capture around one-fifth of revenue share in 2024 with an approximate growth rate of 6% from 2016 to 2024.
Asia Pacific is expected to observe the highest regional growth at an approximate CAGR of 5.6% owing to the rapid industrialization in emerging economies including China, India, and South Korea.
Key players operating in the global industry are ExxonMobil, Royal Dutch Shell, Total S.A, Lukoil, British Petroleum, Chevron Corporation, BASF, The Dow Chemical, Sasol Limited, Sinopec Limited, Croda International and Fuchs Petrolub.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/petrochemicals-and-downstream-derivatives

Grand View Research has segmented the Global Compressor Oil Market on the basis of compressor type, base oil, end-use and region:

Global Compressor Oil Compressor Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2024)

Positive Displacement Compressor
Dynamic Compressor

Global Compressor Oil Base Oil Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2024)

Synthetic
Semi-Synthetic
Mineral
Bio-Based

Global Compressor Oil End Use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2024)

Manufacturing
Oil & Gas
Power
Automotive
Others

Global Compressor Oil Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2024)

North America

U.S
Canada
Mexico

Europe

Germany
UK
France
Spain
Russia

Asia Pacific

China
India
Japan
South Korea
Australia

Middle East and Africa

Saudi Arabia
South Africa
Kuwait
Iraq

Central & South America

Brazil
Argentina
Venezuela

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-compressor-oil-market

Cord Blood Banking (CBB) Service Projected to reach over USD 12 billion by 2022 : Grand View Research,Inc.

Global Market For Cord Blood Banking (CBB) Service is expected to reach over USD 12 billion by 2022, growing at an estimated CAGR of around 11% from 2015 to 2022, according to a new report by Grand View Research, Inc. Key drivers of the market include increasing application of stem cell therapy in disease treatment, and rising prevalence of life threatening genetic disorders.

Moreover, increasing spending capacity is fueling the demand for advanced healthcare facilities including prevention and treatment. As a result, parents are increasingly demanding CBB Service to ensure safety of their child’s future. Furthermore, private players are practicing marketing activities which are creating awareness about the availability of the CBB Service and their benefits.

In addition, governments worldwide are promoting public CBB to develop ethnically diverse cord blood repository which would increase the chances of finding suitable human leukocyte antigen (HLA) match for the patients. As a result, availability of the ethnically rich CB repository coupled with anticipated rise in the stem cell therapies and bone marrow transplants, is expected to spur the CBB Service during the forecast period.

Full Research Report on Global Cord Blood Banking Service Market Analysis:
http://www.grandviewresearch.com/industry-analysis/cord-blood-banking-services-market

Further key findings from the study suggest:

Private bank segment accounted for the largest market share in 2014. High cost of collection, processing, and storage along with the maximum awareness created by marketing activities practiced by the players resulted in large market share of private banks in the world.
Rising government support and no storage and collection costs are the major factors anticipated to drive the public banking segment during the forecast period from 2015 to 2022 with highest CAGR.
North America dominated the global market and was followed by Europe in 2014. Dominance of North America is accounted by government support and high penetration rate of stem cell therapy in the U.S. and Canada. Moreover, high awareness and insurance coverage of cord blood banking and stem cell therapies is further boosting the growth of the market in North America.
Densely populated emerging countries of Asia Pacific are anticipated to show significant growth during the forecast period from 2015 to 2022. Factors such as increasing investment by global players, government support and rising healthcare expenditure are anticipated to boost the cord blood banking Service market in Asia Pacific.
Global cord blood banking Service market is highly fragmented with presence of many private and public players. Few global players operate in various geographies through subsidiaries. While local players are operating independently in respective geographies.
Key players of this market include China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Limited, Cryo-Cell International, Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord, Inc. and Virgin Health Bank

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Cord Blood Banking Service Market on the basis of bank types and region:

Cord Blood Banking Service Outlook, 2012 - 2022, Revenue (USD Million), Volume (Number of Units)

Public Banks
Private Banks

Cord Blood Banking Service Regional Outlook, 2012 - 2022, Revenue (USD Million), Volume (Number of Units)

· North America

· U.S.

§ U.S. Cord Blood Banking Service Market, by Bank Type

· Canada

§ Canada Cord Blood Banking Service Market, by Bank Type

· Europe

· Germany

§ Germany Cord Blood Banking Service Market, by Bank Type

· UK

§ UK Cord Blood Banking Service Market, by Bank Type

· France

§ France Cord Blood Banking Service Market, by Bank Type

· Italy

§ Italy Cord Blood Banking Service Market, by Bank Type

· Asia Pacific

· Japan

§ Japan Cord Blood Banking Service Market, by Bank Type

· China

§ China Cord Blood Banking Service Market, by Bank Type

· India

§ India Cord Blood Banking Service Market, by Bank Type

· Latin America

· Brazil

§ Brazil Cord Blood Banking Service Market, by Bank Type

· MEA

· South Africa

§ South Africa Cord Blood Banking Service Market, by Bank Type

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cord-blood-banking-service-market

Membrane Bioreactor Market Projected to reach USD 8.27 billion by 2025 : Grand View Research,Inc.

Global Membrane BioreactorMarket is expected to reach USD 8.27 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for membrane bioreactor as they offer high-quality solid separation and low carbon footprint will propel industry expansion over the forecast period.

Rising concerns regarding the release of toxic effluents into the environment are expected to result in an increase in the installation of membrane bioreactor solutions in the industrial and manufacturing sector. In addition, stringent environmental regulations on sludge disposal are expected to stimulate demand for highly effective MBR systems.

Increasing MBR installations by various key players including Beijing Origin Water, GE Water, Koch Membrane Systems, and Tianjin MOTIMO as a result of rising industrial wastes by pharmaceuticals, food & beverages, and refinery will promote the market growth over the forecast period. Technology up gradation coupled with cost reductions are expected to drive the product demand over the forecast period.

Municipal accounted for 68.7% of the overall share in 2016 and is expected to witness substantial growth as a result of increasing urban population and government support to promote infrastructure development in Turkey, China, India, Singapore, Thailand, and Bangladesh.

Full Research Report on Global Membrane Bioreactor Market Analysis:
http://www.grandviewresearch.com/industry-analysis/membrane-bioreactor-mbr-market

Further key findings from the report suggest:

Flat sheet MBR is expected to witness significant rise at a CAGR of 18.5% from 2017 to 2025 as a result of increasing adoption in the medium scale industrial waste water treatment plants. Moreover, increasing usage in food & beverage sector owing to its high solid loading and good hydraulic flow behavior is anticipated to fuel demand.
Asia Pacific was the dominant market and accounted for 50.4% of the global membrane bioreactor market in 2016. Establishment of various food & beverage, pharmaceutical, pulp & paper manufacturing units particularly in India and China will fuel MBR demand in industrial waste water sector.
Growing water pollution along with water shortage problems that are currently prevailing in China, India, Singapore and Malaysia is expected to provide ample opportunity for the wastewater treatment industry.
Key participants dominating the membrane bioreactor (MBR) industry includes GE Water & Process Technologies, Toray Industries, Inc., Kubota Corporation, Koch Membrane Systems, Inc., Evoqua Water Technologies LLC, and Mitsubishi Rayon Co., Ltd.
MBR players are adopting numerous strategies for strengthening its foothold across the international market. These companies have been undertaking strategies including new product developments, expansion of installed capacity in order to increase its market penetration.
In July 2015, Cambrian Innovation launched EcoVolt Membrane Bioreactor (MBR). This system will remove over 99% of pollutants and solids, enabling water re-use on site
KMS introduced next generation of improved, high flux PURON modules for membrane bioreactor having built-in reliability, low life-cycle costs, reduced system footprint, and new fiber chemistry

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/water-and-industrial-sludge-treatment

Grand View Research has segmented the Global Membrane Bioreactor (MBR) Market on the basis of product, configuration, application, and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

Hollow fiber
Flat sheet
Multi-tubular

Configuration Outlook (Revenue, USD Million, 2014 - 2025)

Submerged
Side stream

Application Outlook (Revenue, USD Million, 2014 - 2025)

Municipal
Industrial

Food & beverages
Textile
Oil & gas
Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.

Europe

Germany
UK
Italy
France

Asia Pacific

China
Japan

Central & South America

Brazil

Middle East & Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-membrane-bioreactor-mbr-market